Accuvest Global Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,322
Closed -$244K 72
2025
Q4
$244K Sell
2,322
-1,132
-33% -$106K 0.18% 60
2025
Q3
$290K Buy
3,454
+701
+25% +$57.7K 0.18% 48
2025
Q2
$218K Buy
+2,753
New +$219K 0.14% 71
2024
Q1
Sell
-10,000
Closed -$1.09M 122
2023
Q4
$1.09M Buy
+10,000
New +$1.04M 1.16% 20
2021
Q3
Sell
-4,619
Closed -$359K 120
2021
Q2
$359K Buy
4,619
+907
+24% +$67.5K 0.18% 65
2021
Q1
$273K Buy
+3,712
New +$274K 0.15% 74
2019
Q2
Sell
-6,067
Closed -$481K 111
2019
Q1
$481K Sell
6,067
-137
-2% -$10.2K 0.26% 87
2018
Q4
$452K Sell
6,204
-1,590
-20% -$112K 0.23% 68
2018
Q3
$528K Buy
+7,794
New +$497K 0.2% 86

Other funds holding MRK

Accuvest Global Advisors's MRK Position: Q1 2026 in Review

Accuvest Global Advisors sold out of Merck (MRK) in Q1 2026, closing a stake of 2,322 shares — an estimated $244K sold.

Accuvest Global Advisors first reported a position in MRK in Q3 2018 and held it in 9 quarters. The position peaked at $1.09M in Q4 2023. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Accuvest Global Advisors reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Accuvest Global Advisors sold 2,322 Merck shares in Q1 2026, an estimated $244K.
  • Accuvest Global Advisors first reported a position in Merck in Q3 2018 and held it in 9 quarters.
  • Accuvest Global Advisors's Merck position peaked at $1.09M in Q4 2023.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Accuvest Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.